臺灣核心實作指引(TW Core IG)
0.3.1 - Ci-Build Trial Use

臺灣核心實作指引(TW Core IG), published by 衛生福利部. This guide is not an authorized publication; it is the continuous build for version 0.3.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cctwFHIRterm/MOHW_TWCoreIG_Build/ and changes regularly. See the Directory of published versions

Example MedicationDispense: 爽胰達注射劑100單位+50微克藥品配藥資料

爽胰達注射劑100單位50微克藥品配藥資料

配藥的狀態:Completed ( MedicationDispense Status Codes#completed)

配藥的分類: Inpatient ( MedicationDispense Category Codes#inpatient)

配藥的類型:Daily Fill ( V3 Value SetActPharmacySupplyType#DF)

藥品:爽胰達注射劑100單位50微克 ( 臺灣藥品許可證#衛部菌疫輸字第001080號)

病人Patient/pat-example "陳加玲"

就醫資料Encounter/enc-example

配藥者Practitioner/pra-phc-example "陳耀詩"

配藥資料

藥品總劑量:1 Intravenous Solution ( OrderableDrugForm#IVSOL)
藥品天數:3 days
藥品使用方法:每日注射一次,於餐前一小時內注射,建議固定在同一餐的餐前注射
藥品包裝和審核時間:2022-08-01T11:45:00
藥品發放的時間:2022-08-01T12:00:00

藥品替代資料

配藥是否與處方要求不同:none ( SubstanceAdminSubstitution#N)
替代原因:formulary policy ( ActReason#FP)